Breaking News Instant updates and real-time market news.

CRM

Salesforce

$93.24

1.48 (1.61%)

16:11
08/22/17
08/22
16:11
08/22/17
16:11

Technical View: Salesforce drops after results in extended session

Shares were last down over 3.8% to $89.37. At that price next support is at $87.71. Resistance is at $91.

  • 22

    Aug

  • 05

    Sep

CRM Salesforce
$93.24

1.48 (1.61%)

08/22/17
ROTH
08/22/17
NO CHANGE
Target $112
ROTH
Buy
Salesforce price target raised to $112 from $103 at Roth Capital
Roth Capital analyst Richard Baldry raised his price target for Salesforce to $112 from $103 saying earnings comparisons are set to improve materially in Q2 and 2H18. The analyst reiterates a Buy rating on the shares.
08/22/17
BTIG
08/22/17
NO CHANGE
BTIG
Salesforce Q2 results likely to beat expectations, says BTIG
BTIG analyst Joel Fishbein, Jr says his checks with Salesforce's partners have convinced him that the company's Q2 results will beat expectations. The analyst says checks indicate that the company has a strong pipeline and stable pricing, and is benefiting from more "multi-cloud deployments and deeper penetration of the installed base." The analyst says the all of the company's "segments continue to show strength," while its ARPU continues to rise. He keeps a $100 price target and a Buy rating on the shares.
08/21/17
RHCO
08/21/17
NO CHANGE
RHCO
Salesforce Q2 results likely to beat expectations, says SunTrust
SunTrust analyst Terry Tillman expects Salesforce's Q2 results to beat expectations "based on well-balanced growth across (its) Sales, Service, Marketing and Platform businesses." Tillman thinks that the company will perform well in 2H18 due to seasonal billings strength, a number of "Event driven catalysts" including its Dreamforce conference, and the increased monetization of its "newer cloud products." He expects the company's fiscal 2019 results to significantly beat expectations and expects the stock to perform well in the second half of this year. He keeps a $110 price target and a Buy rating on the shares.
08/18/17
RBCM
08/18/17
NO CHANGE
RBCM
Salesforce billings growth can beat expectations, says RBC Capital
RBC Capital analyst Ross MacMillan believes that Salesforce's Q2 billings growth will beat expectations, and he preidtcs that it will raise its full-year revenue growth guidance. The analyst is upbeat on the company's fundamentals and keeps an Outperform rating.

TODAY'S FREE FLY STORIES

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

07:33
09/25/17
09/25
07:33
09/25/17
07:33
Hot Stocks
Spark Therapeutics appoints Dr. Federico Mingozzi as Chief Scientific Officer »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

AGN

Allergan

$204.65

1.99 (0.98%)

07:32
09/25/17
09/25
07:32
09/25/17
07:32
Hot Stocks
Allergan announces new $2B share repurchase plan, affirms guidance »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ECA

Encana

$11.25

-0.05 (-0.44%)

07:31
09/25/17
09/25
07:31
09/25/17
07:31
Recommendations
Encana analyst commentary  »

Encana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Allergan »

Allergan announces new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

, ROK

Rockwell Automation

$177.55

0.22 (0.12%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

ROK

Rockwell Automation

$177.55

0.22 (0.12%)

DVA

DaVita

$57.49

-3.77 (-6.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Periodicals
Nintendo adds two-factor authentication for accounts, the Verge says »

Nintendo (NTDOY) users…

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

EGO

Eldorado Gold

$2.26

0.02 (0.89%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

APRN

Blue Apron

$5.19

-0.04 (-0.76%)

07:28
09/25/17
09/25
07:28
09/25/17
07:28
Initiation
Blue Apron initiated  »

Blue Apron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$188.30

0.39 (0.21%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$51.60

4.8 (10.26%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Cubic analyst commentary  »

Cubic price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$30.05

-0.05 (-0.17%)

07:26
09/25/17
09/25
07:26
09/25/17
07:26
Periodicals
Corning looks to expand Gorilla presence in auto glass market, DigiTimes says »

Corning is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:26
09/25/17
09/25
07:26
09/25/17
07:26
General news
Futures pointing to slightly lower open »

Stock futures are trading…

ALSSF

Alsea

$3.53

-0.1382 (-3.77%)

07:25
09/25/17
09/25
07:25
09/25/17
07:25
Upgrade
Alsea rating change  »

Alsea upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAA

STAAR Surgical

$10.90

0.05 (0.46%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Upgrade
STAAR Surgical rating change  »

STAAR Surgical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.32

0.24 (2.64%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Technical Analysis
Technical View: Transocean trades higher in pre-market, analyst action »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

ZG

Zillow

$38.93

-0.93 (-2.33%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Initiation
Zillow initiated  »

Zillow initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

AMAT

Applied Materials

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Applied Materials analyst commentary  »

Applied Materials analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AEM

Agnico Eagle

$46.74

0.6 (1.30%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Agnico Eagle analyst commentary  »

Agnico Eagle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

DK

Delek US

$25.70

0.25 (0.98%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Conference/Events
Delek US management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

APOP

Cellect Biotechnology

$8.28

0.19 (2.35%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Recommendations
Cellect Biotechnology analyst commentary  »

Cellect Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPX

Louisiana-Pacific

$28.44

0.53 (1.90%)

07:21
09/25/17
09/25
07:21
09/25/17
07:21
Recommendations
Louisiana-Pacific analyst commentary  »

Louisiana-Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSO

CytoSorbents

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Hot Stocks
CytoSorbents highlights publication of study in Journal of Artificial Organs »

CytoSorbents highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMD

CorMedix

$0.47

0.048 (11.37%)

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Recommendations
CorMedix analyst commentary  »

CorMedix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
09/25/17
09/25
07:20
09/25/17
07:20
General news
FX Update: The euro has come under across-the-board pressure »

FX Update: The euro has…

TWTR

Twitter

$17.61

0.03 (0.17%)

07:19
09/25/17
09/25
07:19
09/25/17
07:19
Periodicals
Twitter tests Twitter Lite Android app in the Philippines, TechCrunch says »

Twitter is testing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.